Found: 7
Select item for more details and to access through your institution.
Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas.
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 3, p. 190, doi. 10.1007/s12094-012-0783-5
- By:
- Publication type:
- Article
CD147 Expression Indicates Unfavourable Prognosis in Prostate Cancer.
- Published in:
- Pathology & Oncology Research, 2009, v. 15, n. 3, p. 369, doi. 10.1007/s12253-008-9131-z
- By:
- Publication type:
- Article
Expression of CD147 is associated with prostate cancer progression.
- Published in:
- International Journal of Cancer, 2012, v. 130, n. 2, p. 300, doi. 10.1002/ijc.25982
- By:
- Publication type:
- Article
Over-expression of extracellular matrix metalloproteinase inducer in prostate cancer is associated with high risk of prostate-specific antigen relapse after radical prostatectomy.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer.
- Published in:
- Medical Oncology, 2014, v. 31, n. 1, p. 1, doi. 10.1007/s12032-013-0820-4
- By:
- Publication type:
- Article
Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysis.
- Published in:
- Medical Oncology, 2012, v. 29, n. 4, p. 2877, doi. 10.1007/s12032-011-0149-9
- By:
- Publication type:
- Article
Effects of PPAR-γ on the proliferation and glycolysis metabolism of prostate cancer cells.
- Published in:
- National Journal of Andrology / Zhonghua Nankexue, 2012, v. 18, n. 8, p. 692
- By:
- Publication type:
- Article